Martin E. Swarbrick

1.2k total citations
22 papers, 524 citations indexed

About

Martin E. Swarbrick is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Martin E. Swarbrick has authored 22 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Martin E. Swarbrick's work include Asymmetric Synthesis and Catalysis (5 papers), Phosphorus compounds and reactions (3 papers) and Synthesis and Catalytic Reactions (3 papers). Martin E. Swarbrick is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Phosphorus compounds and reactions (3 papers) and Synthesis and Catalytic Reactions (3 papers). Martin E. Swarbrick collaborates with scholars based in United Kingdom, Canada and Italy. Martin E. Swarbrick's co-authors include William D. Lubell, Francis Gosselin, James C. Anderson, Alan Armstrong, Pavel Kočovský, Andrei V. Malkov, Frédéric Friscourt, Stephen C. Smith, Mark Bell and Alice W. Flaherty and has published in prestigious journals such as Cancer Research, Chemical Communications and The Journal of Organic Chemistry.

In The Last Decade

Martin E. Swarbrick

22 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin E. Swarbrick United Kingdom 12 369 248 59 58 43 22 524
Kathy Sarris United States 13 313 0.8× 213 0.9× 26 0.4× 49 0.8× 31 0.7× 18 515
Kai Schiemann Germany 12 282 0.8× 200 0.8× 44 0.7× 29 0.5× 31 0.7× 17 453
Dušan Berkeš Slovakia 17 327 0.9× 384 1.5× 41 0.7× 21 0.4× 35 0.8× 56 684
Pierrik Lassalas France 7 309 0.8× 158 0.6× 32 0.5× 34 0.6× 34 0.8× 11 477
Lawrence W. Dillard United States 8 292 0.8× 494 2.0× 26 0.4× 95 1.6× 73 1.7× 13 697
Rambabu Reddi India 15 584 1.6× 164 0.7× 72 1.2× 15 0.3× 37 0.9× 22 705
Piotr Raubo United Kingdom 18 494 1.3× 316 1.3× 52 0.9× 15 0.3× 43 1.0× 41 746
Andrew P. Montgomery Australia 11 202 0.5× 181 0.7× 28 0.5× 23 0.4× 17 0.4× 24 395
Stephen T. Wrobleski United States 13 384 1.0× 196 0.8× 28 0.5× 61 1.1× 86 2.0× 16 555
Xiang‐Hong He China 18 805 2.2× 219 0.9× 111 1.9× 21 0.4× 39 0.9× 30 963

Countries citing papers authored by Martin E. Swarbrick

Since Specialization
Citations

This map shows the geographic impact of Martin E. Swarbrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin E. Swarbrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin E. Swarbrick more than expected).

Fields of papers citing papers by Martin E. Swarbrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin E. Swarbrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin E. Swarbrick. The network helps show where Martin E. Swarbrick may publish in the future.

Co-authorship network of co-authors of Martin E. Swarbrick

This figure shows the co-authorship network connecting the top 25 collaborators of Martin E. Swarbrick. A scholar is included among the top collaborators of Martin E. Swarbrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin E. Swarbrick. Martin E. Swarbrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Andrews, David, Sabina Cosulich, Nullin Divecha, et al.. (2021). Identification and optimization of a novel series of selective PIP5K inhibitors. Bioorganic & Medicinal Chemistry. 54. 116557–116557. 7 indexed citations
3.
Healy, Mark P., Andy Billinton, Iain P. Chessell, et al.. (2018). Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 28(10). 1892–1896. 4 indexed citations
4.
Raubo, Piotr, David Andrews, Graeme R. Robb, et al.. (2015). Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα). Bioorganic & Medicinal Chemistry Letters. 25(16). 3189–3193. 11 indexed citations
5.
Andrews, David, Martin E. Swarbrick, & Andrew T. Merritt. (2014). Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface. Drug Discovery Today. 19(4). 496–501. 8 indexed citations
6.
Morley, Andrew, Angelo Pugliese, Kristian Birchall, et al.. (2013). Fragment-based hit identification: thinking in 3D. Drug Discovery Today. 18(23-24). 1221–1227. 129 indexed citations
7.
Waring, Michael J., Darren A.E. Cross, David Andrews, et al.. (2013). Abstract 2228: Phosphatidylinositol-4-kinase - Potent and selective inhibitors of PI4Kα and PI4Kβ.. Cancer Research. 73(8_Supplement). 2228–2228. 1 indexed citations
8.
Waring, Michael J., David Andrews, Paul Faulder, et al.. (2013). Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation. Chemical Communications. 50(40). 5388–5390. 30 indexed citations
9.
Chelucci, Giorgio, Mauro Marchetti, Andrei V. Malkov, et al.. (2011). New monoterpene-derived phosphinopyridine ligands and their application in the enantioselective iridium-catalyzed hydrogenation. Tetrahedron. 67(30). 5421–5431. 21 indexed citations
10.
Gleave, Robert J., Paul Beswick, Andrew J. Brown, et al.. (2009). 2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 19(23). 6578–6581. 9 indexed citations
11.
Gleave, Robert J., Paul Beswick, Andrew J. Brown, et al.. (2009). Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 20(2). 465–468. 34 indexed citations
12.
Armstrong, Alan, et al.. (2005). Electrophilic amination of enolates with oxaziridines: effects of oxaziridine structure and reaction conditions. Tetrahedron. 61(35). 8423–8442. 21 indexed citations
13.
Armstrong, Alan, et al.. (2003). Efficient nitrogen transfer from aldehyde-derived N-acyloxaziridines. Tetrahedron Letters. 44(28). 5335–5338. 31 indexed citations
14.
Anderson, James C., Alice W. Flaherty, & Martin E. Swarbrick. (2000). The Aza-[2,3]-Wittig Sigmatropic Rearrangement of Acyclic Amines:  Scope and Limitations of Silicon Assistance. The Journal of Organic Chemistry. 65(26). 9152–9156. 27 indexed citations
15.
Swarbrick, Martin E. & William D. Lubell. (2000). Stereoconvergent approach for synthesizing enantiopure 5,6-dialkylpipecolic acids. Chirality. 12(5-6). 366–373. 11 indexed citations
16.
Swarbrick, Martin E., Francis Gosselin, & William D. Lubell. (1999). Alkyl Substituent Effects on Pipecolyl Amide Isomer Equilibrium:  Efficient Methodology for Synthesizing Enantiopure 6-Alkylpipecolic Acids and Conformational Analysis of TheirN-AcetylN‘-Methylamides. The Journal of Organic Chemistry. 64(6). 1993–2002. 56 indexed citations
17.
Anderson, James C., et al.. (1998). The aza-[2,3]-Wittig sigmatropic rearrangement of Z(C)-alkenes. Tetrahedron Letters. 39(17). 2649–2650. 7 indexed citations
18.
Anderson, James C., Stephen C. Smith, & Martin E. Swarbrick. (1997). Diastereoselective acyclic aza-[2,3] Wittig sigmatropic rearrangements. Journal of the Chemical Society Perkin Transactions 1. 1517–1522. 9 indexed citations
19.
Anderson, James C., et al.. (1996). The Silicon-Assisted Aza-[2,3]-Wittig Sigmatropic Rearrangement. The Journal of Organic Chemistry. 61(14). 4820–4823. 27 indexed citations
20.
Anderson, James C., et al.. (1995). Aza-[2,3]-Wittig sigmatropic rearrangement of crotyl amines. Journal of the Chemical Society Chemical Communications. 1835–1835. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy Sarris Breakdown of academic impact, for papers by Kai Schiemann Breakdown of academic impact, for papers by Dušan Berkeš Breakdown of academic impact, for papers by Pierrik Lassalas Breakdown of academic impact, for papers by Lawrence W. Dillard Breakdown of academic impact, for papers by Rambabu Reddi Breakdown of academic impact, for papers by Piotr Raubo Breakdown of academic impact, for papers by Andrew P. Montgomery Breakdown of academic impact, for papers by Stephen T. Wrobleski Breakdown of academic impact, for papers by Xiang‐Hong He
Rankless by CCL
2026